Craig, Stephanie G.Anderson, Lesley A.Schache, Andrew G.Moran, MichaelGraham, LauraCurrie, KeithRooney, KeithRobinson, MaxUpile, Navdeep S.Brooker, RachelMesri, MinaBingham, VictoriaMcQuaid, StephenJones, TerryMcCance, Dennis J.Salto-Tellez, ManuelMcDade, Simon S.James, Jacqueline A.2020-06-292020-06-292019-04-16Craig, S G, Anderson, L A, Schache, A G, Moran, M, Graham, L, Currie, K, Rooney, K, Robinson, M, Upile, N S, Brooker, R, Mesri, M, Bingham, V, McQuaid, S, Jones, T, McCance, D J, Salto-Tellez, M, McDade, S S & James, J A 2019, 'Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines : a two-tier approach', British Journal of Cancer, vol. 120, pp. 827-833. https://doi.org/10.1038/s41416-019-0414-90007-0920ORCID: /0000-0002-1000-3649/work/75077280https://hdl.handle.net/2164/14591ACKNOWLEDGEMENTS The funders had no role in study design, collection, data analysis or interpretation of the data. This work received funding from the Medical Research Council (D.Mc.C. and J.J.), the Health and Social Care Research and Development Division of the Northern Ireland Public Health Agency (D.M.c.C., J.J., M.Mo.), the Wellcome Trust through the Wellcome-FDS Research Training Fellowship, the Faculty of Dental Surgery of the Royal College of Surgeons of England (A.G.S.) and GlaxoSmithKline Ltd (T.J.). The Northern Ireland OPSCC TMAs used in this research were received from the Northern Ireland Biobank which has received funds from Health and Social Care Research and Development Division of the Public Health Agency in Northern Ireland and the Friends of the Cancer Centre. The Northern Ireland Cancer Registry who receives funding from the Northern Ireland Public Health Agency carried out collection of clinical data for the Northern Ireland OPSCC patients. The Faculty of Dental Surgery of the Royal College of Surgeons of England and the Liverpool Bio-innovation Hub Biobank carried out collection of clinical data for the Liverpool OPSCC patients.7597983engSDG 3 - Good Health and Well-beinghead and neck cancerprognostic markersR Medicine (General)OncologyCancer ResearchR1Journal article10.1038/s41416-019-0414-9http://www.scopus.com/inward/record.url?scp=85063260131&partnerID=8YFLogxK120